188 results on '"van Putten, Maaike"'
Search Results
2. Learning, memory and blood–brain barrier pathology in Duchenne muscular dystrophy mice lacking Dp427, or Dp427 and Dp140
3. Antisense Oligonucleotide-Mediated Downregulation of IGFBPs Enhances IGF-1 Signaling
4. Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model
5. Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model
6. Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy
7. Voluntary exercise improves muscle function and does not exacerbate muscle and heart pathology in aged Duchenne muscular dystrophy mice
8. Low dystrophin levels are insufficient to normalize the neuromuscular synaptic abnormalities of mdx mice
9. Diffusion‐tensor magnetic resonance imaging captures increased skeletal muscle fibre diameters in Becker muscular dystrophy
10. Environmental 24-hr Cycles Are Essential for Health
11. Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes
12. Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy
13. Evaluation of 2’-Deoxy-2’-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
14. On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics
15. Low dystrophin levels in heart can delay heart failure in mdx mice
16. Preclinical Studies on Intestinal Administration of Antisense Oligonucleotides as a Model for Oral Delivery for Treatment of Duchenne Muscular Dystrophy
17. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains
18. Long-term Exon Skipping Studies With 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models
19. Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle
20. The predictive value of models of neuromuscular disorders to potentiate clinical translation
21. HANDEDNESS AND ASYMMETRY IN SCALE-EATING CICHLIDS: ANTISYMMETRIES OF DIFFERENT STRENGTH
22. Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle
23. Spatial transcriptomics reveal markers of histopathological changes in Duchenne muscular dystrophy mouse models
24. The therapeutic potential of soluble activin type receptor IIB treatment in a limb girdle muscular dystrophy type 2D mouse model
25. A 3 months mild functional test regime does not affect disease parameters in young mdx mice
26. On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics.
27. Efficient Downregulation of Alk4in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy
28. Referee report. For: Identification of quantitative polymerase chain reaction reference genes suitable for normalising gene expression in the brain of normal and dystrophic mice and dogs [version 1; peer review: 1 approved with reservations]
29. 'Of Mice and Measures': A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic
30. Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle.
31. Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy
32. Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model
33. A data‐driven methodology reveals novel myofiber clusters in older human muscles
34. Mouse models for muscular dystrophies: an overview
35. Moving neuromuscular disorders research forward: from novel models to clinical studies
36. Asymmetrical myofiber architecture along the murine tibialis anterior suggests distinct functional regions
37. A data-driven methodology reveals novel myofiber clusters in older human muscles
38. Discovering fiber type architecture over the entire muscle using data‐driven analysis.
39. Asymmetrical myofiber architecture along the murine tibialis anterior suggests distinct functional regions
40. The use of genetically humanized animal models for personalized medicine approaches
41. 240th ENMC workshop: The involvement of skeletal muscle stem cells in the pathology of muscular dystrophies 25–27 January 2019, Hoofddorp, The Netherlands
42. Cross-sectional study into age-related pathology of mouse models for limb girdle muscular dystrophy types 2D and 2F
43. A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy
44. Nonclinical Exon Skipping Studies with 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn−/− Mice Inspired by Clinical Trial Results
45. High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns
46. Author Correction: Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
47. Update on Standard Operating Procedures in Preclinical Research for DMD and SMA Report of TREAT-NMD Alliance Workshop, Schiphol Airport, 26 April 2015, The Netherlands
48. A dystrophic Duchenne mouse model for testing human antisense oligonucleotides
49. 227 th ENMC International Workshop
50. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.